Literature DB >> 7561462

Factors associated with recurrence of cholesteatoma.

E Vartiainen1.   

Abstract

After a mean follow-up period of 7.3 years, a recurrence was found in 43 (12.3 per cent) out of 349 consecutive patients undergoing surgical treatment for acquired cholesteatoma. The great majority of residual cholesteatomas detected in the 'second-look' operations arose from the oval window area. Chronic otorrhoea and a reperforation were the most common signs of late recurrences. In eight ears a recurrent cholesteatoma developed from a retraction pocket. The recurrence rate was higher in children than in adults. The type of surgical technique had no significant effect on recurrence rate. Recurrences were more frequent in pre-operatively discharging ears than in dry ears. Some suggestions have been made to improve the results of surgery for cholesteatoma.

Entities:  

Mesh:

Year:  1995        PMID: 7561462     DOI: 10.1017/s0022215100130804

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  8 in total

1.  Optical imaging with a high-resolution microendoscope to identify cholesteatoma of the middle ear.

Authors:  Lauren L Levy; Nancy Jiang; Eric Smouha; Rebecca Richards-Kortum; Andrew G Sikora
Journal:  Laryngoscope       Date:  2013-01-08       Impact factor: 3.325

2.  Modified intact canal wall mastoidectomy - long term results in hearing and healing.

Authors:  A Mahadevaiah; Bhavin Parikh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2009-01-28

3.  Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism.

Authors:  Matthias Schürmann; Felix Oppel; Senyao Shao; Verena Volland-Thurn; Christian Kaltschmidt; Barbara Kaltschmidt; Lars-Uwe Scholtz; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2021-02-24       Impact factor: 5.712

4.  Evaluating hearing outcome, recidivism and complications in cholesteatoma surgery using the ChOLE classification system.

Authors:  David Bächinger; Adrian Rrahmani; Nora M Weiss; Robert Mlynski; Alexander Huber; Christof Röösli
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-07-13       Impact factor: 2.503

Review 5.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

6.  Multiwavelength fluorescence otoscope for video-rate chemical imaging of middle ear pathology.

Authors:  Tulio A Valdez; Rishikesh Pandey; Nicolas Spegazzini; Kaitlyn Longo; Corrie Roehm; Ramachandra R Dasari; Ishan Barman
Journal:  Anal Chem       Date:  2014-10-01       Impact factor: 6.986

7.  Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications?

Authors:  Mohammed Hassan Hussain; Manish Mair; Sara Mahmood; Georgios Sakagiannis; Djamila M Rojoa; Firas J Raheman; Esmee Irvine; Peter Rea
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-10       Impact factor: 2.503

8.  Identification of risk factors for residual cholesteatoma in children and adults: a retrospective study on 110 cases of revision surgery.

Authors:  Veronika Volgger; Göran Lindeskog; Eike Krause; Florian Schrötzlmair
Journal:  Braz J Otorhinolaryngol       Date:  2018-12-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.